Aiswariya Chidambaram is a Management Consultant Project Leader with more than a decade of experience in the Pharmaceutical & Biotechnology sector. She has worked with several leading life sciences consulting firms, including Indegene, Frost & Sullivan, and SAI MedPartners, wherein she has consulted and provided strategic solutions to several Fortune 500 pharmaceutical and biotech firms across the globe. Ms. Chidambaram has authored over fifteen research reports and over thirty publications including whitepapers and thought-leader interviews for reputed journals and magazines on key therapeutic and service areas including Generics, Biosimilars, Regenerative Medicine, Vaccines, and Contract Manufacturing, among others. Not only this, she has participated in reputed industry conferences such as CPhI Europe, CPhI Japan, India, Singapore, NDDS China, Pharma Tech India, United Pharma Journals & Conferences, USA in the capacity of keynote speaker, panelist, and judge. As part of the industry best practice research, she has awarded leading pharmaceutical companies, including, Boehringer Ingelheim, Merck Serono, Paras Biopharmaceuticals, Protein Sciences, etc. for demonstrating excellence in specific market/product segments and technologies. Here is an excerpt from a conversation with her.